Back to top
more

IDEXX Laboratories (IDXX)

(Real Time Quote from BATS)

$419.39 USD

419.39
299,328

-4.26 (-1.01%)

Updated Nov 15, 2024 01:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 250)

Industry: Medical - Instruments

Zacks News

Should You Invest in the First Trust Water ETF (FIW)?

Sector ETF report for FIW

IDXX Q3 Earnings Top, '24 Sales View Down, Stock Dips in Premarket

IDXX's Q3 revenues benefit from strong growth in its CAG and Water segments.

Idexx (IDXX) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Idexx Laboratories (IDXX) Q3 Earnings Surpass Estimates

Idexx (IDXX) delivered earnings and revenue surprises of 4.09% and 0.41%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Penumbra (PEN) Q3 Earnings and Revenues Top Estimates

Penumbra (PEN) delivered earnings and revenue surprises of 23.19% and 0.99%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Seeking Clues to Idexx (IDXX) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics

Evaluate the expected performance of Idexx (IDXX) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Waters (WAT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?

Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IDXX Gears Up for Q3 Earnings: What to Expect From the Stock?

IDEXX Laboratories' third-quarter 2024 performance is expected to have benefited from a strong execution against strategic priorities.

Nandini Tamret headshot

Are Options Traders Betting on a Big Move in IDEXX Laboratories (IDXX) Stock?

Investors need to pay close attention to IDEXX Laboratories (IDXX) stock based on the movements in the options market lately.

Should iShares Russell Mid-Cap Growth ETF (IWP) Be on Your Investing Radar?

Style Box ETF report for IWP

Why Is Idexx (IDXX) Up 0.9% Since Last Earnings Report?

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Do Options Traders Know Something About IDEXX (IDXX) Stock We Don't?

Investors need to pay close attention to IDEXX (IDXX) stock based on the movements in the options market lately.

IDEXX (IDXX) Q2 Earnings Miss Estimates, 2024 View Down

IDEXX's (IDXX) Q2 earnings miss estimates but revenues meet the same.

Idexx (IDXX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Idexx Laboratories (IDXX) Lags Q2 Earnings Estimates

Idexx (IDXX) delivered earnings and revenue surprises of -14.98% and 0.11%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

The Zacks Analyst Blog Baxter International, Henry Schein and IDEXX Laboratories

Baxter International, Henry Schein and IDEXX Laboratories are included in this Analyst Blog.

Urmimala Biswas headshot

What's in Store for These 3 MedTech Stocks in Q2 Earnings?

MedTech companies' quarterly results are likely to be strong on a sequential basis. Let's see how BAX, HSIC and IDXX are placed ahead of their earnings releases.

Unlocking Q2 Potential of Idexx (IDXX): Exploring Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Idexx (IDXX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.

Will KORU Medical Systems Inc. (KRMD) Report Negative Earnings Next Week? What You Should Know

KORU Medical Systems Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?

Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Strong CAG Sales to Aid IDEXX Laboratories' (IDXX) Q2 Earnings

IDEXX Laboratories' (IDXX) second-quarter 2024 results are likely to reflect the benefits of strong execution against the growth strategy.

TMO or IDXX: Which Is the Better Value Stock Right Now?

TMO vs. IDXX: Which Stock Is the Better Value Option?

IDEXX (IDXX) Business Faces Macroeconomic Woes, FX Headwinds

IDEXX's (IDXX) supply chain operations bear the brunt of geopolitical instability, including the current war in Ukraine.

Why Is Penumbra (PEN) Down 4.8% Since Last Earnings Report?

Penumbra (PEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.